![](https://www.e-med.co.il/wp-content/uploads/2022/06/default-312x200.jpg)
FDA Approves Avapro (Irbesartan) For The Treatment Of Diabetic Nephropathy (Kidney Disease) In Patients With High Blood Pressure And Type 2 Diabetes
Bristol-Myers Squibb Company (NYSE: BMY) and Sanofi-Synthelabo (Euronext: SAN; NYSE: SNY) announced today that the U.S. Food